1. The Nurse View: Updates in the Management of Metastatic Colorectal Cancer

4. Colorectal Cancer

5. Management of Patients With mCRC Overview

6. Case Study: Mr M Background

7. Case Study: Mr M Treatment History

8. Considerations for Second-Line Therapy in mCRC

9. Strategies for Communicating With and Educating Patients

10. Including Patients and Caregivers in Treatment Decisions

11. Second-Line Treatment Options for mCRC

12. Guidelines for Second-Line mCRC Treatment

13. Guidelines for Second-Line mCRC Treatment (cont)

14. Case Study: Mr. M (cont)

16. Managing Chemotherapy-Related Diarrhea

17. Prevention of Chemotherapy-Induced Peripheral Neuropathy

18. Management of Chemotherapy-Induced Peripheral Neuropathy

19. Anti-VEGF-Associated Hypertension

21. Bevacizumab-Related AEs

23. Case Study: Mr M (cont) Review of Case

24. Case Study: Mr M (cont)

25. NCCN mCRC Treatment Guideline Third-Line Treatment

26. Regorafenib Overview

27. Regorafenib Dosing and Administration

28. Regorafenib Adverse Events

29. Hand-Foot Syndrome vs Hand-Foot Skin Reaction

30. Preventing and Managing HFSR

31. Trifluridine-Tipiracil Overview

32. Trifluridine-Tipiracil Dosing and Administration

33. Trifluridine-Tipiracil Adverse Events

34. Nivolumab and Pembrolizumab Overview

35. Nivolumab and Pembrolizumab Adverse Events

36. Abbreviations

37. Abbreviations (cont)